OPB
4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE
Find entries where: OPB
is present as a standalone ligand in 3 entries
Chemical Component Summary | |
---|---|
Name | 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE-3,5-DIONE |
Synonyms | OXYPHENBUTAZONE |
Identifiers | (4S)-4-butyl-1-(4-hydroxyphenyl)-2-phenyl-pyrazolidine-3,5-dione |
Formula | C19 H20 N2 O3 |
Molecular Weight | 324.374 |
Type | NON-POLYMER |
Isomeric SMILES | CCCC[C@H]1C(=O)N(N(C1=O)c2ccc(cc2)O)c3ccccc3 |
InChI | InChI=1S/C19H20N2O3/c1-2-3-9-17-18(23)20(14-7-5-4-6-8-14)21(19(17)24)15-10-12-16(22)13-11-15/h4-8,10-13,17,22H,2-3,9H2,1H3/t17-/m0/s1 |
InChIKey | HFHZKZSRXITVMK-KRWDZBQOSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 44 |
Chiral Atom Count | 1 |
Bond Count | 46 |
Aromatic Bond Count | 12 |
Drug Info: DrugBank
DrugBank ID | DB03585? |
---|---|
Name | Oxyphenbutazone |
Groups |
|
Description | Oxyphenbutazone was withdrawn from the Canadian market in March 1985 due to concerns regarding bone marrow suppression. |
Synonyms |
|
Brand Names |
|
Categories |
|
ATC-Code |
|
CAS number | 129-20-4 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Group IIE secretory phospholipase A2 | MKSPHVLVFLCLLVALVTGNLVQFGVMIEKMTGKSALQYNDYGCYCGIGG... | unknown | |
Serum albumin | MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA... | unknown | |
Solute carrier family 22 member 6 | MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCR... | unknown | inhibitor |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL1235001 |
PubChem | 448033 |
ChEMBL | CHEMBL1235001 |